Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 40

1.

Exploratory data analysis of a clinical study group: Development of a procedure for exploring multidimensional data.

Konopka BM, Lwow F, Owczarz M, Łaczmański Ł.

PLoS One. 2018 Aug 23;13(8):e0201950. doi: 10.1371/journal.pone.0201950. eCollection 2018.

2.

Distinguishing mirtrons from canonical miRNAs with data exploration and machine learning methods.

Rorbach G, Unold O, Konopka BM.

Sci Rep. 2018 May 15;8(1):7560. doi: 10.1038/s41598-018-25578-3.

3.

Clinical importance of the EMSY gene expression and polymorphisms in ovarian cancer.

Dansonka-Mieszkowska A, Szafron LM, Moes-Sosnowska J, Kulinczak M, Balcerak A, Konopka B, Kulesza M, Budzilowska A, Lukasik M, Piekarska U, Rzepecka IK, Parada J, Zub R, Pienkowska-Grela B, Madry R, Siwicki JK, Kupryjanczyk J.

Oncotarget. 2018 Apr 3;9(25):17735-17755. doi: 10.18632/oncotarget.24878. eCollection 2018 Apr 3.

4.

Contrasting effects of environmental change on the radial growth of co-occurring beech and fir trees across Europe.

Bosela M, Lukac M, Castagneri D, Sedmák R, Biber P, Carrer M, Konôpka B, Nola P, Nagel TA, Popa I, Roibu CC, Svoboda M, Trotsiuk V, Büntgen U.

Sci Total Environ. 2018 Feb 15;615:1460-1469. doi: 10.1016/j.scitotenv.2017.09.092. Epub 2017 Oct 19.

5.

Forecasting residue-residue contact prediction accuracy.

Wozniak PP, Konopka BM, Xu J, Vriend G, Kotulska M.

Bioinformatics. 2017 Nov 1;33(21):3405-3414. doi: 10.1093/bioinformatics/btx416.

6.

Role of Bioinformatics in the Study of Ionic Channels.

Kurczyńska M, Konopka BM, Kotulska M.

Adv Anat Embryol Cell Biol. 2017;227:17-37. doi: 10.1007/978-3-319-56895-9_2. Review.

PMID:
28980038
7.

Quantiprot - a Python package for quantitative analysis of protein sequences.

Konopka BM, Marciniak M, Dyrka W.

BMC Bioinformatics. 2017 Jul 17;18(1):339. doi: 10.1186/s12859-017-1751-4.

8.

No Evidence That Genetic Variation in the Myeloid-Derived Suppressor Cell Pathway Influences Ovarian Cancer Survival.

Sucheston-Campbell LE, Cannioto R, Clay AI, Etter JL, Eng KH, Liu S, Battaglia S, Hu Q, Szender JB, Minlikeeva A, Joseph JM, Mayor P, Abrams SI, Segal BH, Wallace PK, Soh KT, Zsiros E, Anton-Culver H, Bandera EV, Beckmann MW, Berchuck A, Bjorge L, Bruegl A, Campbell IG, Campbell SP, Chenevix-Trench G, Cramer DW, Dansonka-Mieszkowska A, Dao F, Diergaarde B, Doerk T, Doherty JA, du Bois A, Eccles D, Engelholm SA, Fasching PA, Gayther SA, Gentry-Maharaj A, Glasspool RM, Goodman MT, Gronwald J, Harter P, Hein A, Heitz F, Hillemmanns P, Høgdall C, Høgdall EV, Huzarski T, Jensen A, Johnatty SE, Jung A, Karlan BY, Klapdor R, Kluz T, Konopka B, Kjær SK, Kupryjanczyk J, Lambrechts D, Lester J, Lubiński J, Levine DA, Lundvall L, McGuire V, McNeish IA, Menon U, Modugno F, Ness RB, Orsulic S, Paul J, Pearce CL, Pejovic T, Pharoah P, Ramus SJ, Rothstein J, Rossing MA, Rübner M, Schildkraut JM, Schmalfeldt B, Schwaab I, Siddiqui N, Sieh W, Sobiczewski P, Song H, Terry KL, Van Nieuwenhuysen E, Vanderstichele A, Vergote I, Walsh CS, Webb PM, Wentzensen N, Whittemore AS, Wu AH, Ziogas A, Odunsi K, Chang-Claude J, Goode EL, Moysich KB; Australian Ovarian Cancer Study.

Cancer Epidemiol Biomarkers Prev. 2017 Mar;26(3):420-424. doi: 10.1158/1055-9965.EPI-16-0631. Epub 2016 Sep 27.

9.

The significance of c.690G>T polymorphism (rs34529039) and expression of the CEBPA gene in ovarian cancer outcome.

Konopka B, Szafron LM, Kwiatkowska E, Podgorska A, Zolocinska A, Pienkowska-Grela B, Dansonka-Mieszkowska A, Balcerak A, Lukasik M, Stachurska A, Timorek A, Spiewankiewicz B, El-Bahrawy M, Kupryjanczyk J.

Oncotarget. 2016 Oct 11;7(41):67412-67424. doi: 10.18632/oncotarget.11822.

10.

Applying PyRosetta molecular energies to separate properly oriented protein models from mirror models, obtained from contact maps.

Kurczynska M, Kania E, Konopka BM, Kotulska M.

J Mol Model. 2016 May;22(5):111. doi: 10.1007/s00894-016-2975-3. Epub 2016 Apr 23.

11.

Fast assessment of structural models of ion channels based on their predicted current-voltage characteristics.

Dyrka W, Kurczyńska M, Konopka BM, Kotulska M.

Proteins. 2016 Feb;84(2):217-31. doi: 10.1002/prot.24967. Epub 2016 Jan 7.

PMID:
26650347
12.

The putative oncogene, CRNDE, is a negative prognostic factor in ovarian cancer patients.

Szafron LM, Balcerak A, Grzybowska EA, Pienkowska-Grela B, Podgorska A, Zub R, Olbryt M, Pamula-Pilat J, Lisowska KM, Grzybowska E, Rubel T, Dansonka-Mieszkowska A, Konopka B, Kulesza M, Lukasik M, Kupryjanczyk J.

Oncotarget. 2015 Dec 22;6(41):43897-910. doi: 10.18632/oncotarget.6016.

13.

The Novel Gene CRNDE Encodes a Nuclear Peptide (CRNDEP) Which Is Overexpressed in Highly Proliferating Tissues.

Szafron LM, Balcerak A, Grzybowska EA, Pienkowska-Grela B, Felisiak-Golabek A, Podgorska A, Kulesza M, Nowak N, Pomorski P, Wysocki J, Rubel T, Dansonka-Mieszkowska A, Konopka B, Lukasik M, Kupryjanczyk J.

PLoS One. 2015 May 15;10(5):e0127475. doi: 10.1371/journal.pone.0127475. eCollection 2015.

14.

Germline SMARCA4 mutations in patients with ovarian small cell carcinoma of hypercalcemic type.

Moes-Sosnowska J, Szafron L, Nowakowska D, Dansonka-Mieszkowska A, Budzilowska A, Konopka B, Plisiecka-Halasa J, Podgorska A, Rzepecka IK, Kupryjanczyk J.

Orphanet J Rare Dis. 2015 Mar 15;10:32. doi: 10.1186/s13023-015-0247-4.

15.

Evaluating the significance of protein functional similarity based on gene ontology.

Konopka BM, Golda T, Kotulska M.

J Comput Biol. 2014 Nov;21(11):809-22. doi: 10.1089/cmb.2014.0181. Epub 2014 Sep 4.

PMID:
25188814
16.

Automated procedure for contact-map-based protein structure reconstruction.

Konopka BM, Ciombor M, Kurczynska M, Kotulska M.

J Membr Biol. 2014 May;247(5):409-20. doi: 10.1007/s00232-014-9648-x. Epub 2014 Mar 29.

17.

Ovarian small cell carcinoma of hypercalcemic type - evidence of germline origin and SMARCA4 gene inactivation. a pilot study.

Kupryjańczyk J, Dansonka-Mieszkowska A, Moes-Sosnowska J, Plisiecka-Hałasa J, Szafron L, Podgórska A, Rzepecka IK, Konopka B, Budziłowska A, Rembiszewska A, Grajkowska W, Spiewankiewicz B.

Pol J Pathol. 2013 Dec;64(4):238-46.

18.

p19(INK4d) mRNA and protein expression as new prognostic factors in ovarian cancer patients.

Felisiak-Golabek A, Dansonka-Mieszkowska A, Rzepecka IK, Szafron L, Kwiatkowska E, Konopka B, Podgorska A, Rembiszewska A, Kupryjanczyk J.

Cancer Biol Ther. 2013 Oct 1;14(10):973-81. doi: 10.4161/cbt.25966. Epub 2013 Aug 14.

19.

Quality assessment of protein model-structures based on structural and functional similarities.

Konopka BM, Nebel JC, Kotulska M.

BMC Bioinformatics. 2012 Sep 21;13:242. doi: 10.1186/1471-2105-13-242.

20.

PIK3CA mutations and amplification in endometrioid endometrial carcinomas: relation to other genetic defects and clinicopathologic status of the tumors.

Konopka B, Janiec-Jankowska A, Kwiatkowska E, Najmoła U, Bidziński M, Olszewski W, Goluda C.

Hum Pathol. 2011 Nov;42(11):1710-9. doi: 10.1016/j.humpath.2010.01.030. Epub 2011 Apr 29.

PMID:
21531001
21.

TP53 mutations in endometrial cancers: relation to PTEN gene defects.

Janiec-Jankowska A, Konopka B, Goluda C, Najmoła U.

Int J Gynecol Cancer. 2010 Feb;20(2):196-202.

PMID:
20169661
22.

Molecular genetic defects in endometrial carcinomas: microsatellite instability, PTEN and beta-catenin (CTNNB1) genes mutations.

Konopka B, Janiec-Jankowska A, Czapczak D, Paszko Z, Bidziński M, Olszewski W, Goluda C.

J Cancer Res Clin Oncol. 2007 Jun;133(6):361-71. Epub 2007 Jan 12.

PMID:
17219201
23.

Low frequency of the CHEK2*1100delC mutation among breast cancer probands from three regions of Poland.

Kwiatkowska E, Skasko E, Niwinska A, Wojciechowska-Lacka A, Rachtan J, Molong L, Nowakowska D, Konopka B, Janiec-Jankowska A, Paszko Z, Steffen J.

Neoplasma. 2006;53(4):305-8.

PMID:
16830057
24.

PTEN mutation, expression and LOH at its locus in ovarian carcinomas. Relation to TP53, K-RAS and BRCA1 mutations.

Kolasa IK, Rembiszewska A, Janiec-Jankowska A, Dansonka-Mieszkowska A, Lewandowska AM, Konopka B, Kupryjańczyk J.

Gynecol Oncol. 2006 Nov;103(2):692-7. Epub 2006 Jun 21.

PMID:
16793127
25.

Contrasting net primary productivity and carbon distribution between neighboring stands of Quercus robur and Pinus sylvestris.

Curiel Yuste J, Konôpka B, Janssens IA, Coenen K, Xiao CW, Ceulemans R.

Tree Physiol. 2005 Jun;25(6):701-12.

PMID:
15805090
26.

The coexistence of ERBB2, INT2, and CMYC oncogene amplifications and PTEN gene mutations in endometrial carcinoma.

Konopka B, Janiec-Jankowska A, Paszko Z, Goluda M.

J Cancer Res Clin Oncol. 2004 Feb;130(2):114-21. Epub 2003 Dec 9.

PMID:
14663583
27.

Assessment of the quality and frequency of mutations occurrence in PTEN gene in endometrial carcinomas and hyperplasias.

Konopka B, Paszko Z, Janiec-Jankowska A, Goluda M.

Cancer Lett. 2002 Apr 8;178(1):43-51.

PMID:
11849740
28.
29.

Work-site physical fitness programs. Comparing the impact of different program designs on cardiovascular risks.

Heirich MA, Foote A, Erfurt JC, Konopka B.

J Occup Med. 1993 May;35(5):510-7.

PMID:
8515323
30.

Immunoreactive and estrogen-binding estrogen receptors, and progestin receptor levels in uterine leiomyomata and their parental myometrium.

Chrapusta S, Konopka B, Paszko Z, Sieinski W, Szamborski J.

Eur J Gynaecol Oncol. 1990;11(4):275-81.

PMID:
2245811
31.

[Immunocytochemical evaluation of estrogen receptors in histological specimens of primary breast cancer].

Gorczyca W, Olszewski W, Woyke S, Chrapusta S, Konopka B, Paszko Z.

Patol Pol. 1990;41(1-2):58-66. Polish.

PMID:
2100791
32.

Estrogen and progestin receptor levels in uterine leiomyomata: relation to the tumour histology and the phase of menstrual cycle.

Chrapusta S, Sieinski W, Konopka B, Szamborski J, Paszko Z.

Eur J Gynaecol Oncol. 1990;11(5):381-7.

PMID:
2097155
33.

[Determining estrogen receptors in neoplastic and normal human tissues: comparison of immunoenzyme and radioligand methods].

Chrapusta S, Konopka B, Paszko Z, Padzik H.

Nowotwory. 1988 Apr-Jun;38(2):87-94. Polish. No abstract available.

PMID:
3067220
34.

[Morphological structure of uterine myomas and levels of estrogen and progestagen receptors].

Sieiński W, Chrapusta S, Konopka B, Paszko Z, Chmielewski M, Szamborski J.

Nowotwory. 1988 Jan-Mar;38(1):29-34. Polish. No abstract available.

PMID:
3405786
35.

[Levels of estrogen and progestagen receptors in uterine myomas in women during the menstrual cycle].

Chrapusta S, Sieiński W, Konopka B, Paszko Z, Szamborski J.

Nowotwory. 1988 Jan-Mar;38(1):23-8. Polish. No abstract available.

PMID:
3405785
36.

[Levels of estrogen and progestagen receptors in the endometrium and myometrium of women during the menstrual cycle].

Chrapusta S, Konopka B, Goluda M, Padzik H, Ujec M, Paszko Z.

Nowotwory. 1988 Jan-Mar;38(1):16-22. Polish. No abstract available.

PMID:
3405784
37.

[Nuclear estrogen receptors in women with breast cancer].

Konopka B, Paszko Z.

Nowotwory. 1988 Jan-Mar;38(1):1-8. Polish. No abstract available.

PMID:
3405783
38.

[Steroid hormone receptors; their appearance in breast cancer; usefulness of the findings in the selection of patients for endocrine therapy and prognosis of tumor development].

Paszko Z, Padzik H, Pieńkowska F, Chrapusta S, Konopka B, Peczko D.

Pol Tyg Lek. 1983 May 30-Jun 6;38(22-23):677-83. Polish. No abstract available.

PMID:
6647135
39.

Metabolic effects of facial cooling in exercise.

Riggs CE Jr, Johnson DJ, Kilgour RD, Konopka BJ.

Aviat Space Environ Med. 1983 Jan;54(1):22-6.

PMID:
6830553
40.

Exercise heart rate response to facial cooling.

Riggs CE Jr, Johnson DJ, Konopka BJ, Kilgour RD.

Eur J Appl Physiol Occup Physiol. 1981;47(4):323-30.

PMID:
7199435

Supplemental Content

Loading ...
Support Center